Homepage
Author:
4D Molecular Therapeutics, Inc.
Posted Date:
April 17, 2026
4DMT Announces New Employment Inducement Grants
4D Molecular Therapeutics, Inc.
April 17, 2026
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
4D Molecular Therapeutics, Inc.
March 18, 2026
4DMT to Participate in Upcoming Investor Meetings
4D Molecular Therapeutics, Inc.
March 16, 2026
4DMT to Participate in Upcoming Investor Conferences
4D Molecular Therapeutics, Inc.
February 19, 2026
4DMT Announces New Employment Inducement Grants
4D Molecular Therapeutics, Inc.
February 13, 2026
4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
4D Molecular Therapeutics, Inc.
February 9, 2026
